Cite
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
MLA
Rogers, James L., et al. “Provider-Reported Challenges and Barriers to Referring Patients to Neuro-Oncology Clinical Trials: A Report from the Society for Neuro-Oncology Member Survey.” Neuro-Oncology Practice, vol. 7, no. 1, Feb. 2020, pp. 38–51. EBSCOhost, https://doi.org/10.1093/nop/npz038.
APA
Rogers, J. L., Acquaye, A., Vera, E., Bates, A., Wen, P. Y., & Armstrong, T. S. (2020). Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey. Neuro-Oncology Practice, 7(1), 38–51. https://doi.org/10.1093/nop/npz038
Chicago
Rogers, James L, Alvina Acquaye, Elizabeth Vera, Amanda Bates, Patrick Y Wen, and Terri S Armstrong. 2020. “Provider-Reported Challenges and Barriers to Referring Patients to Neuro-Oncology Clinical Trials: A Report from the Society for Neuro-Oncology Member Survey.” Neuro-Oncology Practice 7 (1): 38–51. doi:10.1093/nop/npz038.